Skip to main content
. Author manuscript; available in PMC: 2021 Apr 11.
Published in final edited form as: J Clin Lipidol. 2018 Mar 14;12(4):937–947.e2. doi: 10.1016/j.jacl.2018.03.080

Figure 2.

Figure 2

Mean percent change from baseline at 1-year follow-up for WOMAC scores aoccording to the intention-to-treat (panel A) and per-protocol analysis (Panel B) in the control and Lovaza groups. A lower % change indicates less pain and stiffness and better physical function. WOMAC indicates Western Ontario and McMaster Universities Arthritis Index.